- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
U.S. House Oversight and Government Reform Subcommittee Holds Hearing on Drug Shortages
Congressional hearings on drug shortages continue due in part to continued efforts of the American Society of Clinical Oncology (ASCO) and the medical community to raise awareness and seek solutions to this crisis. On Nov. 30, the U.S. House of Representatives Oversight and Government Reform Subcommittee on Health Care, District of Columbia, Census and the National Archives convened a hearing on the issue.
Michelle Hudspeth, MD, director of the Pediatric Hematology/Oncology Division at the Medical University of South Carolina, testified that “the current situation is nothing short of a massive national emergency” and that the shortages were severely impacting cancer care.
Dr. Hudspeth also discussed why she felt the reimbursement model created through the Medicare Modernization Act of 2003 has helped lead to the shortages.
Read the full report at: http://tinyurl.com/7xta8rv
Source: Oncology Business Review; ASCO
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
